A total of 63 adult patients with SAIDs were included in this study, among whom 44 (69.8%) carried combined variants in two or more genes, and there were 19 (30.2%) YAOS patients with characteristic clinical features and the specific NOD2 variants. This evidence concerns the gene NOD2 and Yao syndrome.